Clinical Investigation| Volume 351, ISSUE 6, P589-594, June 2016

Download started.


Changes in Inflammatory and Bone Turnover Markers After Periodontal Disease Treatment in Patients With Diabetes

Published:February 24, 2016DOI:



      The underlying mechanisms for increased osteopenia and fracture rates in patients with diabetes are not well understood, but may relate to chronic systemic inflammation. We assessed the effect of treating periodontal disease (POD), a cause of chronic inflammation, on inflammatory and bone turnover markers in patients with diabetes.

      Materials and Methods

      Using an investigator-administered questionnaire, we screened a cross-section of patients presenting for routine outpatient diabetes care. We recruited 22 subjects with POD. Inflammatory and bone turnover markers were measured at baseline and 3 months following POD treatment (scaling, root planing and subantimicrobial dose doxycycline).


      There were nonsignificant reductions in high-sensitivity C-reactive protein (6.34–5.52 mg/L, P = 0.626) and tumor necrosis factor-alpha (10.37–10.01 pg/mL, P = 0.617). There were nonsignificant increases in urinary C-terminal telopeptide (85.50–90.23 pg/mL, P = 0.684) and bone-specific alkaline phosphatase (7.45–8.79 pg/mL, P = 0.074). Patients with >90% adherence with doxycycline were 6.4 times more likely to experience reduction in tumor necrosis factor-alpha (P = 0.021) and 2.8 times more likely to experience reductions in high-sensitivity C-reactive protein (P = 0.133).


      Treatment of POD in patients with diabetes resulted in nonsignificant lowering of inflammatory markers and nonsignificant increase in bone turnover markers. However, adherence to doxycycline therapy resulted in better treatment effects.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Martin J.A.
        • Page R.C.
        • Loeb C.F.
        • et al.
        Tooth loss in 776 treated periodontal patients.
        J Periodontol. 2010; 81: 244-250
        • Takata T.
        • Donath K.
        The mechanism of pocket formation. A light microscopic study on undecalcified human material.
        J Periodontol. 1988; 59: 215-221
        • Taylor G.W.
        • Borgnakke W.S.
        Periodontal disease: associations with diabetes, glycemic control and complications.
        Oral Dis. 2008; 14: 191-203
        • D׳Aiuto F.
        • Parkar M.
        • Andreou G.
        • et al.
        Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers.
        J Dent Res. 2004; 83: 156-160
        • D׳Aiuto F.
        • Ready D.
        • Tonetti M.S.
        Periodontal disease and C-reactive protein-associated cardiovascular risk.
        J Periodontal Res. 2004; 39: 236-241
        • Cochran D.L.
        Inflammation and bone loss in periodontal disease.
        J Periodontol. 2008; 79: 1569-1576
        • Pejcic A.
        • Kesic L.J.
        • Milasin J.
        C-reactive protein as a systemic marker of inflammation in periodontitis.
        Eur J Clin Microbiol Infect Dis. 2011; 30: 407-414
      1. Centers for Disease Control and Prevention. National Diabetes Statistics Report: estimates of Diabetes and Its Burden in the United States, 2014. U.S. Department of Health and Human Services 2014.

        • Engebretson S.
        • Kocher T.
        Evidence that periodontal treatment improves diabetes outcomes: a systematic review and meta-analysis.
        J Periodontol. 2013; 84: S153-S169
        • Jeevanantham V.
        • Singh N.
        • Izuora K.
        • et al.
        Correlation of high sensitivity C-reactive protein and calcific aortic valve disease.
        Mayo Clin Proc. 2007; 82: 171-174
        • Izuora K.E.
        • Chase H.P.
        • Jackson W.E.
        • et al.
        Inflammatory markers and diabetic retinopathy in type 1 diabetes.
        Diabetes Care. 2005; 28: 714-715
        • Ridker P.M.
        • Cushman M.
        • Stampfer M.J.
        • et al.
        Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
        N Engl J Med. 1997; 336: 973-979
        • Koh J.M.
        • Khang Y.H.
        • Jung C.H.
        • et al.
        Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis.
        Osteoporos Int. 2005; 16: 1263-1271
        • Armour K.E.
        • Van THRJ
        • Grabowski P.S.
        • et al.
        Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis.
        J Bone Miner Res. 1999; 14: 2137-2142
        • Ding C.
        • Parameswaran V.
        • Udayan R.
        • et al.
        Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study.
        J Clin Endocrinol Metab. 2008; 93: 1952-1958
        • Janghorbani M.
        • Van Dam R.M.
        • Willett W.C.
        • et al.
        Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture.
        Am J Epidemiol. 2007; 166: 495-505
        • Vidal F.
        • Figueredo C.M.
        • Cordovil I.
        • et al.
        Periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension.
        J Periodontol. 2009; 80: 786-791
        • D׳Aiuto F.
        • Parkar M.
        • Nibali L.
        • et al.
        Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial.
        Am Heart J. 2006; 151: 977-984
        • Izuora K.
        • Ezeanolue E.
        • Schlauch K.
        • et al.
        Impact of periodontal disease on outcomes in diabetes.
        Contemp Clin Trials. 2015; 41: 93-99
        • Rudolph J.W.
        • Hirsch I.B.
        Assessment of therapy with continuous subcutaneous insulin infusion in an academic diabetes clinic.
        Endocr Pract. 2002; 8: 401-405
        • Pejcic A.
        • Kesic L.
        • Milasin J.
        Association between periodontopathogens and CRP levels in patients with periodontitis in Serbia.
        J Dent Res Dent Clin Dent Prospects. 2011; 5: 10-16
        • Engebretson S.P.
        • Hyman L.G.
        • Michalowicz B.S.
        • et al.
        The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial.
        J Am Med Assoc. 2013; 310: 2523-2532
      2. Owens JB, Wilder RS, Southerland JH, et al. North Carolina internists׳ and endocrinologists׳ knowledge, opinions, and behaviors regarding periodontal disease and diabetes: need and opportunity for interprofessional education. J Dent Educ 2011;75(3): 329-338.

        • Lin H.
        • Zhang H.
        • Yan Y.
        • et al.
        Knowledge, awareness, and behaviors of endocrinologists and dentists for the relationship between diabetes and periodontitis.
        Diabetes Res Clin Pract. 2014; 106: 428-434
        • Tasdemir Z.
        • Alkan B.A.
        Knowledge of medical doctors in Turkey about the relationship between periodontal disease and systemic health.
        Braz Oral Res. 2015; 29: 55
        • Al-Khabbaz A.K.
        • Al-Shammari K.F.
        • Al-Saleh N.A.
        Knowledge about the association between periodontal diseases and diabetes mellitus: contrasting dentists and physicians.
        J Periodontol. 2011; 82: 360-366
        • American Diabetes Association
        Standards of medical care in diabetes—2013.
        Diabetes Care. 2013; 36: S11-S66
      3. International Diabetes Federation Clinical Guidelines Task Force. Guideline on oral health for people with diabetes. International Diabetes Federation 2009.

        • Lockhart P.B.
        • Bolger A.F.
        • Papapanou P.N.
        • et al.
        Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association? a scientific statement from the American Heart Association.
        Circulation. 2012; 125: 2520-2544
        • Tonetti M.S.
        • Van Dyke T.E.
        Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases.
        J Clin Periodontol. 2013; 40: S24-S29
        • Dodd D.Z.
        • Rowe D.J.
        The relationship between postmenopausal osteoporosis and periodontal disease.
        J Dent Hyg. 2013; 87: 336-344
        • Engebretson S.P.
        • Hey-Hadavi J.
        Sub-antimicrobial doxycycline for periodontitis reduces hemoglobin A1c in subjects with type 2 diabetes: a pilot study.
        Pharmacol Res. 2011; 64: 624-629